No Efficacy Seen for Intranasal Oxytocin in Children/Adolescents With Autism Spectrum Disorder
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder
N. Engl. J. Med 2021 Oct 14;385(16)1462-1473, L Sikich, A Kolevzon, BH King, CJ McDougle, KB Sanders, SJ Kim, M Spanos, T Chandrasekhar, MDP Trelles, CM Rockhill, ML Palumbo, A Witters Cundiff, A Montgomery, P Siper, M Minjarez, LA Nowinski, S Marler, LC Shuffrey, C Alderman, J Weissman, B Zappone, JE Mullett, H Crosson, N Hong, SK Siecinski, SN Giamberardino, S Luo, L She, M Bhapkar, R Dean, A Scheer, JL Johnson, SG Gregory, J Veenstra-VanderWeeleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.